Five regulatory myths keeping bio/pharma out of digital health
DHIT2017-10-30T08:30:22-04:00By Bradley Merrill Thompson and Chris Bergstrom | Oct 27, 2017 About the Authors: Bradley Merrill Thompson is a member of the firm at Epstein Becker & Green, P.C. There, he counsels medical device, drug, and combination product companies on a wide range of FDA regulatory issues. Chris Bergstrom is a digital health leader, for The [...]